At a glance
ClinicalIndex Comparison RecordN/ACompleted· 21 enrolled
Drug / intervention
Timolol-dorzolamide (Glaucoma drops) +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Prospective, Randomized Study Comparing the Effects of Topical Aqueous Suppressants on Intraocular Gas Duration Following Scleral Buckling and Pneumatic Retinopexy.
In Brief
A clinical study evaluating Timolol-dorzolamide (Glaucoma drops) and standard post-operative topical drops for Scleral Buckling. Completed, enrolled 21 participants across 1 site.
Detailed Summary
A controlled clinical study comparing the effect of topical aqueous suppressants on intraocular gas duration.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsScleral Buckling
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
2011201220132014201520162017201820192020202120222023202420252026
Enrollment StartJun 2011
Primary CompletionApr 2013
First PostedMay 2013
TodayJul 2026
First PostedMay 1, 2013
Enrollment StartJun 1, 2011
Primary CompletionApr 1, 2013
TodayJul 2, 2026
Enrollment to primary: 1.8 yearsPosted 13.2 years ago
Interventions
Timolol-dorzolamide (Glaucoma drops)drug
Patients will receive the standard post-operative drops regardless of what group you are in. The glaucoma drops will only be given to the experimental group.
standard post-operative topical dropsdrug
Patients will receive the standard post-operative drops regardless of what group ther are in. The standard post-operative drops are Prednisolone acetate,Polymyxin B and Trimethoprim